Dr Ikenna K Obioma, MD | |
169 Martin Ave, Ephrata, PA 17522-1734 | |
(717) 733-0311 | |
(717) 721-5861 |
Full Name | Dr Ikenna K Obioma |
---|---|
Gender | Male |
Speciality | |
Experience | Years |
Location | 169 Martin Ave, Ephrata, Pennsylvania |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1740257492 | NPI | - | NPPES |
100500704 | Medicaid | NV |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207L00000X | Anesthesiology | MD438244 (Pennsylvania) | Primary |
207L00000X | Anesthesiology | 10473 (Nevada) | Secondary |
Mailing Address | Practice Location Address |
---|---|
Dr Ikenna K Obioma, MD 601 Memory Ln, York, PA 17402-2231 Ph: (717) 851-1405 | Dr Ikenna K Obioma, MD 169 Martin Ave, Ephrata, PA 17522-1734 Ph: (717) 733-0311 |
News Archive
Research in the College of Veterinary Medicine at Kansas State University is leading to a better understanding of the molecular interactions in the thyroid gland related to cystic fibrosis.
Results from the PROfound phase III study, funded by AstraZeneca and Merck Sharp & Dohme, open up a much-needed new treatment avenue for the more precise and effective treatment of patients with metastatic castration-resistant prostate cancer (mCRPC) whose disease has progressed with hormonal therapy.
If chronic lymphocytic leukemia patients with a good or poor prognosis could be identified already at the time of diagnosis, physicians would have better possibilities to adjust their therapeutic and follow-up strategies. Now researchers at Uppsala University, together with international colleagues, have discovered a new correlation between specific molecular features of the disease and subgroups of patients with different prognosis.
Cell biologists pondering the death of neurons - brain cells - said today that by eliminating one ingredient from the cellular machinery, they prolonged the life of neurons stressed by a pesticide chemical. The finding identifies a potential therapeutic target to slow changes that lead to neurodegenerative disorders such as Parkinson's and Alzheimer's diseases.
› Verified 2 days ago
Robert A Garvin, D.O. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 169 Martin Ave, Ephrata, PA 17522 Phone: 717-859-4533 Fax: 717-859-4475 | |
Brian R Melamed, PH.D., M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 169 Martin Ave, Ephrata, PA 17522 Phone: 717-859-4533 Fax: 717-859-4475 | |
Alan Berkowitz, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 169 Martin Ave, Ephrata, PA 17522 Phone: 717-859-4533 | |
Chang Su Lee, DO Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 169 Martin Avenue, Ephrata, PA 17522 Phone: 717-859-4533 Fax: 717-859-4475 | |
Dr. Jeffrey B Musser, DO Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 169 Martin Ave, Ephrata, PA 17522 Phone: 717-733-0311 | |
Sarah May Manmiller, Anesthesiology Medicare: Medicare Enrolled Practice Location: 169 Martin Ave, Ephrata, PA 17522 Phone: 717-733-0311 Fax: 717-721-5861 |